BARALDI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 2274
EU - Europa 932
AS - Asia 347
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3561
Nazione #
US - Stati Uniti d'America 2266
IT - Italia 209
DE - Germania 190
CN - Cina 188
PL - Polonia 186
TR - Turchia 111
UA - Ucraina 94
SE - Svezia 76
GB - Regno Unito 57
BE - Belgio 56
VN - Vietnam 32
RU - Federazione Russa 27
FI - Finlandia 26
CA - Canada 8
IN - India 5
FR - Francia 4
AT - Austria 3
CL - Cile 3
AU - Australia 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
NL - Olanda 2
SA - Arabia Saudita 2
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
HK - Hong Kong 1
ID - Indonesia 1
JP - Giappone 1
KH - Cambogia 1
LK - Sri Lanka 1
Totale 3561
Città #
Fairfield 360
Woodbridge 354
Ann Arbor 207
Warsaw 186
Chandler 178
Houston 162
Seattle 143
Wilmington 138
Ashburn 136
Jacksonville 123
Cambridge 119
Ferrara 102
Beijing 65
Izmir 58
Brussels 56
Milan 36
Nanjing 35
Princeton 34
Dong Ket 31
San Diego 23
Boardman 20
Bremen 19
Addison 18
Shenyang 14
Nanchang 13
Jiaxing 11
Changsha 10
Hebei 10
Munich 10
Des Moines 8
Falls Church 8
London 8
Mcallen 7
Redwood City 7
Montréal 6
Norwalk 6
Auburn Hills 5
Jinan 5
Kunming 5
Los Angeles 5
Tianjin 5
Bari 4
Dearborn 4
Padova 4
Philadelphia 4
San Mateo 4
Zhengzhou 4
Helsinki 3
Mountain View 3
Mysore 3
Calvizzano 2
Düsseldorf 2
Indiana 2
Kitzbuhel 2
Lanzhou 2
New York 2
Orange 2
Salice Salentino 2
Toronto 2
Xian 2
Ardabil 1
Augusta 1
Bologna 1
Brentford 1
Camerino 1
Changchun 1
Chicago 1
Colombo 1
Cormeilles-en-Parisis 1
Dallas 1
Guangzhou 1
Haikou 1
Hangzhou 1
Hanoi 1
Herzliya 1
Holmdel 1
Leawood 1
Mansfield 1
Ningbo 1
Nole 1
Pishgaman 1
Porto 1
Redmond 1
Seriate 1
Shanghai 1
Simi Valley 1
Stockholm 1
Taizhou 1
Tel Aviv 1
Tokyo 1
Vienna 1
Yellow Springs 1
Totale 2831
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 260
Design and Synthesis of New A2B Adenosine Receptor Antagonists 174
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 144
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 138
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 135
2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition 131
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 128
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 126
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 126
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 124
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 121
null 121
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 121
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents 120
null 118
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 113
A3 adenosine receptor antagonists: History and future perspectives 113
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 108
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 107
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists. 106
null 103
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 101
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 99
null 96
null 90
null 84
null 83
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 82
Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cells 65
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 42
A 2a adenosine receptor: Structures, modeling, and medicinal chemistry 39
3-Aryl/Heteroaryl-5-amino-1-(3′,4′,5′-trimethoxybenzoyl)-1,2,4-triazoles as antimicrotubule agents. Design, synthesis, antiproliferative activity and inhibition of tubulin polymerization 37
Adenosine Receptors in Colon Carcinoma Tissues and Colon Tumoral Cell Lines: Focus on the A3 Adenosine Subtype 20
Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists 17
Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists 16
Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists. 16
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors 13
Synthesis and Biological Evaluation of Novel 2-Amino-3-Aroyl-4-Neopentyl-5-Substituted Thiophene Derivatives as Allosteric Enhancers of the A1 Adenosine Receptor 11
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists 7
Totale 3655
Categoria #
all - tutte 6327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 334
Totale 6661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201836 0000 00 00 42093
2018/2019575 14111012 1418 519 4786124179
2019/2020836 1213536124 6584 7277 73705128
2020/2021695 47373766 7754 2879 281216259
2021/2022441 26253425 3634 2324 274036111
2022/2023439 4159867 5855 4061 50000
Totale 3655